Profiel
Helena Pozios was the founder of Bouche B Sprl, founded in 2015, and held the title of Chief Executive Officer from 2015 to 2020.
Current jobs include Director at Antigon SA since 2022; Head- Venture Capital at Sambrinvest SA since 2019; Board Member at Tools4patient SA since 2019; Member of the Investment Committee at Innovation Fund (BE) since 2019; Member of the Investment Committee at Theodorus Investment Funds since 2019; Board Member at Lys Medical SRL since 2020; Board Member at Spentys SA since 2020; Board Member at InhaTarget Therapeutics SRL since 2020; Board Member at ConvEyXo SA since 2020; and Board Member at Brussels South Charleroi.
BioPark Dev SA since 2019.
Education history includes a graduate degree from ESSEC Business School conferred in 2005 and an undergraduate degree from Université Paris-Saclay conferred in 2001.
Actieve functies van Helena Pozios
| Bedrijven | Functie | Begin |
|---|---|---|
Sambrinvest SA
Sambrinvest SA Investment ManagersFinance Sambrinvest invests in companies located in Charleroi region. The firm focuses on industry, materials, food industry and life sciences. It participates in the form of debt and equity for early stage capital transactions. | Chief Investment Officer | - |
Tools4patient SA
Tools4patient SA Packaged SoftwareTechnology Services Develops and commercializes clinical development analytical tools to pharmaceutical & biotechnology companies | Directeur/Bestuurslid | 01-04-2019 |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Private Equity Investor | 01-01-2019 |
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund invests in companies located in Belgium. The firm targets companies operating in the fields of process technology, material science, hygiene & cosmetology, bio-sciences, recycling technology and chemical sector. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 0.25 - 0.75 million. | Private Equity Investor | 01-01-2019 |
ConvEyXo SA
ConvEyXo SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused develops therapeutic power of RNA-enhanced exosomes | Directeur/Bestuurslid | 01-01-2020 |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Directeur/Bestuurslid | 01-01-2020 |
Lys Medical SRL
Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Directeur/Bestuurslid | 01-01-2020 |
Spentys SA
Spentys SA Medical SpecialtiesHealth Technology Develops orthopaedic immobilization devices | Directeur/Bestuurslid | 01-01-2020 |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Develops, manufactures and supplies blood safety transfusion device | Directeur/Bestuurslid | 14-06-2022 |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Helena Pozios
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░ ░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Helena Pozios
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sambrinvest SA
Sambrinvest SA Investment ManagersFinance Sambrinvest invests in companies located in Charleroi region. The firm focuses on industry, materials, food industry and life sciences. It participates in the form of debt and equity for early stage capital transactions. | Finance |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Develops, manufactures and supplies blood safety transfusion device | Health Technology |
Tools4patient SA
Tools4patient SA Packaged SoftwareTechnology Services Develops and commercializes clinical development analytical tools to pharmaceutical & biotechnology companies | Technology Services |
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund invests in companies located in Belgium. The firm targets companies operating in the fields of process technology, material science, hygiene & cosmetology, bio-sciences, recycling technology and chemical sector. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 0.25 - 0.75 million. | Finance |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Finance |
Lys Medical SRL
Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Spentys SA
Spentys SA Medical SpecialtiesHealth Technology Develops orthopaedic immobilization devices | Health Technology |
Université Paris-Saclay
Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Health Technology |
ConvEyXo SA
ConvEyXo SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused develops therapeutic power of RNA-enhanced exosomes | Commercial Services |
Brussels South Charleroi BioPark Dev SA | |
Bouche B Sprl |
















